APO866 activity in hematologic malignancies: A preclinical in vitro study

Blood

Volumn 113, Issue 23, 2009, Pages 6035-6037

  Cea, Michele ^a   Zoppoli, Gabriele ^a   Bruzzone, Santina ^a   Fruscione, Floriana ^a   Moran, Eva ^a   Garuti, Anna ^a   Rocco, Ilaria ^a   Cirmena, Gabriella ^a   Casciaro, Salvatore ^a   Olcese, Francesca ^a   Pierri, Ivana ^a   Cagnetta, Antonia ^a   Ferrando, Fabio ^a   Ghio, Riccardo ^a   Gobbi, Marco ^a   Ballestrero, Alberto ^a   Patrone, Franco ^a   Nencioni, Alessio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APO 866; LIPOCORTIN 5; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG; ACRYLAMIDE DERIVATIVE; N (4 (1 BENZOYLPIPERIDIN 4 YL)BUTYL) 3 (PYRIDIN 3 YL)ACRYLAMIDE; N-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL)-3-(PYRIDIN-3-YL)ACRYLAMIDE; PIPERIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LETTER; PRIORITY JOURNAL; APOPTOSIS; BLOOD DISEASE; DRUG EFFECT; DRUG SCREENING; NOTE;

ACRYLAMIDES; APOPTOSIS; DRUG EVALUATION, PRECLINICAL; HEMATOLOGIC NEOPLASMS; HUMANS; PIPERIDINES;

EID: 67651083680     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-209213     Document Type: Letter

References (5)

1. Nahimana A, Attinger A, Aubry D, et al. The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematological malignancies. Blood. 2009;113:3276-3286.
2. Bruzzone S, Moreschi I, Guida L, Usai C, Zocchi E, De Flora A. Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes. Biochem J. 2006;393:697-704. (Pubitemid 43163809)
3. Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003;63:7436-7442. (Pubitemid 37413486)
4. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 1991;51:2515-2520.
5. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1:1112-1116.